Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention

American Heart Journal

Volumn 145, Issue 3, 2003, Pages 529-534

  Gruberg, Luis ^a   Weissman, Neil J ^a   Pichard, Augusto D ^a   Waksman, Ron ^a   Kent, Kenneth M ^a   Satler, Lowell F ^a   Suddath, William O ^a   Pinnow, Ellen E ^a   Gevorkian, Natalie ^a   Lindsay Jr , Joseph ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SURVIVAL; TREATMENT OUTCOME;

EID: 0037352828     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.121     Document Type: Article

References (32)

1. Jungers P, Massy ZA, Khoa TN, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997;12:2597-602.
2. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 1999;56:324-32.
3. Gruberg L, Fuchs S, Waksman R, et al. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency. Catheter Cardiovasc Interv 2002;55:174-9.
4. Rubenstein MH, Sheynberg BV, Harrell LC, et al. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 2001;87:856-60.
5. Rubenstein MH, Harrell LC, Sheynberg BV, et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-72.
6. Asinger RW, Henry TD, Herzog CA, et al. Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence. J Invasive Cardiol 2001;13:21-8.
7. Bourassa MG, Fisher LD, Campeau L, et al. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985;72(5 Suppl):V-71-8.
8. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984;53:102-107C.
9. Fitzgibban GM, Burton JR, Leach AJ. Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and 1132 after one year. Circulation 1978;57:1070-4.
10. Seides SF, Borer JS, Kent KM, et al. Long-term anatomic fate of coronary artery bypass grafts and functional status of patients five years after operation. N Engl J Med 1978;298:1213-7.
11. Tan K, Henderson R, Sulke N, et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting: ten years' experience. Cath Cardiovasc Diagn 1994;31:11-7.
12. Morrison D, Crowley S, Veerakul G, et al. Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina. J Am Coll Cardiol 1994;23:1066-70.
13. Webb JG, Myler RK, Shaw RE, et al. Coronary angioplasty after coronary bypass surgery: initial results and late outcome in 422 patients. J Am Coll Cardiol 1990;16:812-20.
14. Platko WP, Hollman J, Whitlow PL, et al. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up. J Am Coll Cardiol 1989;14:1645-50.
15. Dorros G, Lewin RF, Mathiak LM. Coronary angioplasty in patients with prior coronary artery bypass surgery: all prior coronary artery bypass surgery patients and patients more than 5 years after coronary bypass surgery. Cardlol Clin 1989;7:791-803.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: the Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 2000;36:959-69.
18. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;52:409-16.
19. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of intergentional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-8.
20. Reul GJ, Cooley DA, Ott DA, et al. Reoperation for recurrent coronary artery disease: causes, indications and results in 168 patients. Arch Surg 1979;114:1269-75.
21. Pidgeon J, Brooks N, Magee P, et al. Reoperation for angina after previous aortocoronary bypass surgery. Br Heart J 1985;53:269-75.
22. Choussat R, Black AJ, Bossi I, et al. Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents. J Am Coll Cardiol 2000;36:387-94.
23. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter US Palmaz-Schatz Stent Experience. J Am Coll Cardiol 1995;26:704-12.
24. de Jaegere PP, van Domburg RT, Feyter PJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996;28:89-96.
25. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
26. Savage MP, Douglas JS, Sischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7.
27. Mann JFE, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-36.
28. Wanner C, Quaschning T. Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens 2001;10:195-201.
29. Parfrey PS. Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence and risk. Am J Kidney Dis 2001;37:154-6.
30. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation 1998;97:916-31.
31. Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001;16:1189-97.
32. Kronenberg F, Kuen E, Ritz E, et al. Lipoprotein (a) serum concentrations and apoliprotein (a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000;11:105-15.